摘要
目的了解临床分离的82株嗜麦芽窄食单胞菌的临床分布及药敏情况，为治疗嗜麦芽窄食单胞菌感染提供依据。方法用VITEK-32型微生物鉴定系统GNI^＋卡对82株嗜麦芽窄食单胞菌进行鉴定，并用K-B法进行药物敏感试验。结果82株嗜麦芽窄食单胞菌在临床标本中痰标本有78株，占95．1％，感染主要发生在重症监护病房（ICU）、呼吸科、脑外科等病区。该菌对左氧氟沙星、米诺环素、环丙沙星、复方新诺明较为敏感，敏感率分别为73．2％、69．5％、62．2％、57．3％。结论嗜麦芽窄食单胞菌对常规药物的耐药率较高，临床治疗应根据微生物室的药敏结果合理用药。
Objective To study the drug sensitivity and clinical distribution of 82 clinical isolates of Stenotrophomonas maltophilia and provide clinical guidance for treatment. Methods 82 clinical isolates of Stenotrophomonas maltophilia were identified with GNI^＋ cards of VITEK-32. Drug sensitivities were detected by Kirby-Bauer disc diffusion method. Results 78 strains were isolated from sputum （95.1%）. Infection caused by Stenotrophomonas maltophilia usually occurred at the department of ICU, respiratory diseases, brain surgery, et al. Results of susceptiblity test showed that Stenotrophomonas maltophilia were highly sensitive to Levofloxain, Minocycline, Ciprofloxacin, Sulfamethoxazole/Trimethoprim, which sensitive rate was 73.2%, 69.5%, 62.2%, 57.3%, respectively. Conclusions Stenotrophomonas maltophilia are highly resistant to routine drugs .It is necessary to treat according to its susceptibility tests
出处
《世界感染杂志》
2008年第2期118-119,共2页
World Journal of Infection
关键词
嗜麦芽窄食单胞菌
药敏
感染
Stenotrophomonas maltophilia
susceptiblity test
infection
